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However, it was observed that the lab receipt time for these
patients was equivalent to our baseline. Using the HPC
parameter and a cutoff of 30, mobilization was adequately
predicted 86.4% of the time. For Table 1 n¼66.Table 1
HPC > 30 HPC < 30
CD34+ > 10 56.1% 6.1%
CD34+ < 5 7.6% 30.3%Conclusion: Based on these ﬁndings, it was determined that
this approach for evaluating patient readiness for collection
provides an opportunity to reduce time from arrival in the
donor room to start of collection. However, further adjust-
ments in communication and scheduling the delivery of the
product to the processing laboratory is required to take
advantage of the earlier availability of the product. Upon
further investigation, the earlier arrival of products coincided
with times that had been historically underutilized and had
been repurposed for lab meetings and other tasks. This
approach does provide an opportunity to reduce downtime
in the overall process and better control utilization of
resources.
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Patient satisfaction is an overall goal for every clinical area,
and many hospitals utilize a standardized survey tool to
obtain data on how each speciﬁc inpatient or outpatient area
of the hospital is performing. The satisfaction of our patients
in the outpatient setting has been a primary focus of the UNC
Bone Marrow & Stem Cell Transplant Program. With larger
patient volumes, improving patient satisfaction scores
remains a priority.
During the ﬁrst quarter of 2011, our Press Ganey Patient
Satisfaction Scores e the measurement tool utilized by our
facility - was in the 78th percentile (for large health care
systems nationally). Realizing the frequency with which BMT
patients must spend time in the clinic setting, patient satis-
faction is crucial. At the close of Fiscal Year 2012, our BMT
Clinic ascended to the 95th percentile and was the top rated
clinic of all 84 outpatient clinics in our hospital system.
Creating an afternoon Clinic Huddle to review patients for
the following day was an integral part of improving patient
satisfaction. This huddle includes any teammember who has
a patient scheduled to be seen the next day. By meeting each
afternoon, communication within the team improved
substantially. Nurses had less confusion about labs reques-
ted, APPs were clear which orders needed to be written and
nurse coordinators reviewed any patient issues with the
group. Multidisciplinary updates provide an entire picture of
the patient. These huddles augmented team communication
to the point where add-on lab draws decreased substantially
over the ﬁrst year.
A separate phlebotomy area was established and patients
arrive at least thirty minutes prior to their appointment tohave labs drawn. This enables results to be in hand by the
time the provider sees the patient which expedites their
ability to create a plan of care while the patient remains in
the clinic.
Rounding occurred more frequently once patients were in
the exam room. Listening to the voice of the patient helped to
identify areas for improvement such as modifying pre-
transplant education or waiting room niceties.
Continuing to improve patient satisfaction is a vital
programmatic initiative as the number of patients we care
for in the outpatient setting continues to grow exponentially
as our transplant numbers increase annually. The ﬂexibility
of this Program's team to embrace new practices in order to
beneﬁt our patients' outpatient experience is a process
change worth sharing.492
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Background: Antibody titers from vaccinations adminis-
tered prior to hematopoietic stem cell transplant (HSCT) for
vaccine-preventable diseases (e.g., tetanus, polio) decline 2-5
years after both allogeneic and autologous HSCT. The lack of
protective titers to vaccine preventable diseases poses
a threat to the immunosuppressed patient population. At
Memorial Sloan-Kettering Cancer Center, data indicate that
among those eligible to receive vaccination post HSCT, many
were not timely immunized or did not receive full recom-
mended series. An immunization clinic for this population
was established to increase access, provide timely vaccina-
tion administration, and decrease risk to vaccine preventable
disease for this population.
Population: Patients with leukemia, lymphoma or plasma
cell disorders at minimum of 9 months post allogeneic or
autologous HSCT, referred by a primary practitioner.
Project Description: To establish a centralized clinic led by
an advanced practice nurse dedicated to the immunization of
the HSCT population. The approach consisted of a multi-
phase implementation: implementation of standardized
treatment guidelines, creation of patient and staff education
materials, and the creation and implementation of
computer-based data collection systems.
Conclusion: Preliminary results of this project demonstrate
that the establishment of a centralized immunization clinic
increases access to care, improves patient education, and
promotes use of standardized guidelines at this institution.
This clinic served over 179 HSCT patients, cataloguing 363
unique visits, within its ﬁrst 12 months of inception. This
presentation will include data related to the feasibility of
establishing a vaccination clinic as an effective intervention
for purposes of increasing access and standardizing
evidence-based patient care. Data presented will include the
barriers to clinic implementation, rate of vaccination since
clinic inception, and the development of a documentation
system for data capture related to post HSCT immunization
practices. Increasing access and providing comprehensive
immunization treatment plans for this patient population
may reduce risk to vaccine preventable diseases.
